These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 12650806)
1. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806 [TBL] [Abstract][Full Text] [Related]
2. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Lin OS; Keeffe EB; Sanders GD; Owens DK Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169 [TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms. Parikh ND; Singal AG; Hutton DW; Tapper EB Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012. Gounder PP; Bulkow LR; Meltzer MI; Bruce MG; Hennessy TW; Snowball M; Spradling PR; Adhikari BB; McMahon BJ Int J Circumpolar Health; 2016; 75():31115. PubMed ID: 27197711 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449 [TBL] [Abstract][Full Text] [Related]
8. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis. Worland T; Harrison B; Delmenico L; Dowling D J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients. Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening. Kuo MJ; Chen HH; Chen CL; Fann JC; Chen SL; Chiu SY; Lin YM; Liao CS; Chang HC; Lin YS; Yen AM World J Gastroenterol; 2016 Mar; 22(12):3460-70. PubMed ID: 27022228 [TBL] [Abstract][Full Text] [Related]
12. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population. Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565 [TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI. Mulgaonkar A; Huang DQ; Siddiqi H; Fowler K; Sirlin CB; Marks R; Loomba R; Konijeti GG Am J Gastroenterol; 2024 Jul; 119(7):1326-1336. PubMed ID: 38146873 [TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis. Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164 [TBL] [Abstract][Full Text] [Related]
16. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein. Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192 [TBL] [Abstract][Full Text] [Related]
17. Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Snowberger N; Chinnakotla S; Lepe RM; Peattie J; Goldstein R; Klintmalm GB; Davis GL Aliment Pharmacol Ther; 2007 Nov; 26(9):1187-94. PubMed ID: 17944733 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Sarasin FP; Giostra E; Hadengue A Am J Med; 1996 Oct; 101(4):422-34. PubMed ID: 8873514 [TBL] [Abstract][Full Text] [Related]
19. Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation. Chen QF; Chen S; Yi JZ; Wang JL; Zhong SX; Jiang XY; Hu Y; Tan GJ; Xu J; Lyu N; Zhao M Am J Gastroenterol; 2024 Oct; 119(10):2052-2060. PubMed ID: 38526213 [TBL] [Abstract][Full Text] [Related]
20. Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. Tayob N; Christie I; Richardson P; Feng Z; White DL; Davila J; Corley DA; Kanwal F; El-Serag HB Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1886-1893.e5. PubMed ID: 30557738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]